Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 758 to 807 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase epsilon subunit b (ec 2.7.7.7) (dna polymerase ii subunit b). [source:swissprot;acc:p56282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3760.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4185.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11316\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, type c (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme c) (pfk-c) (6-phosphofructokinase, platelet type). [source:swissprot;acc:q01813]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4254.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4736.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11315\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal 38kda, v0 subunit d isoform 2. [source:refseq;acc:nm\_152565]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5870.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor if-2. [source:swissprot;acc:o60841]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5811.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6467.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1129\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pms1 protein homolog 2 (dna mismatch repair protein pms2). [source:swissprot;acc:p54278]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6231.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6933.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11275\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, muscle type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme a) (pfk-a) (phosphofructokinase-m). [source:swissprot;acc:p08237]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4250.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4729.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11272\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
764\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, liver type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme b) (pfk-b). [source:swissprot;acc:p17858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4250.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4729.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11269\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
765\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polymerase (dna directed) sigma; topoisomerase-related function protein 4-1; polymerase (dna-directed) sigma. [source:refseq;acc:nm\_006999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4726.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5258.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11268\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 1 isoform b; dna-binding protein. [source:refseq;acc:nm\_003349]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6691.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7445.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11255\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
utp--glucose-1-phosphate uridylyltransferase 2 (ec 2.7.7.9) (udp- glucose pyrophosphorylase 2) (udpgp 2) (ugpase 2). [source:swissprot;acc:q16851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6691.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7444.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11254\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
768\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 2; 1 alpha,25-dihydroxyvitamin d3-inducible; enterocyte differentiation promoting factor; methyl methanesulfonate sensitive 2, s. cerevisiae, homolog of. [source:refseq;acc:nm\_003350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6690.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7443.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11253\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit f (ec 3.6.3.14) (v-atpase f subunit) (vacuolar proton pump f subunit) (v-atpase 14 kda subunit). [source:swissprot;acc:q16864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5873.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6532.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11214\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
770\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 2 (ec 3.6.3.14) (v-atpase g subunit 2) (vacuolar proton pump g subunit 2) (v-atpase 13 kda subunit 2). [source:swissprot;acc:o95670]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
771\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor 5; fibroblast growth factor 2-interacting factor 2; api5-like 1. [source:refseq;acc:nm\_006595]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sec13-related protein. [source:swissprot;acc:p55735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
773\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 3 (ec 3.6.3.14) (v-atpase g subunit 3) (vacuolar proton pump g subunit 3) (v-atpase 13 kda subunit 3). [source:swissprot;acc:q96lb4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
yeast sec31p homolog. [source:refseq;acc:nm\_014933]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
775\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 1 (ec 3.6.3.14) (v-atpase g subunit 1) (vacuolar proton pump g subunit 1) (v-atpase 13 kda subunit 1) (vacuolar atp synthase subunit m16). [source:swissprot;acc:o75348]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.33\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
776\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1-like 1. [source:refseq;acc:nm\_024034]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 39 isoform 1; nuclear rna helicase, decd variant of dead box family. [source:refseq;acc:nm\_005804]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, kidney isoform (ec 3.6.3.14) (v- atpase b1 subunit) (vacuolar proton pump b isoform 1) (endomembrane proton pump 58 kda subunit). [source:swissprot;acc:p15313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.23\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase 28 kda accessory protein). [source:swissprot;acc:q9y5k8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit h (ec 3.6.3.14) (v-atpase h subunit) (vacuolar proton pump h subunit) (v-atpase 50/57 kda subunits) (vacuolar proton pump subunit sfd) (cgi-11). [source:swissprot;acc:q9ui12]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.33\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
783\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, brain isoform (ec 3.6.3.14) (v-atpase b2 subunit) (vacuolar proton pump b isoform 2) (endomembrane proton pump 58 kda subunit) (ho57). [source:swissprot;acc:p21281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.37\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1121\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit e (ec 3.6.3.14) (v-atpase e subunit) (vacuolar proton pump e subunit) (v-atpase 31 kda subunit) (p31). [source:swissprot;acc:p36543]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
785\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hemk protein homolog (ec 2.1.1.-) (m.hsahemkp). [source:swissprot;acc:q9y5r4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4997\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5557.17\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
786\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate carboxylase, mitochondrial precursor (ec 6.4.1.1) (pyruvic carboxylase) (pcb). [source:swissprot;acc:p11498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9304.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10347.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11204\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
787\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 2 (v-atpase 116-kda isoform a2) (tj6). [source:swissprot;acc:q9y487]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5890.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6547.9\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11161\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
788\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 3 (v- atpase 116-kda isoform a3) (osteoclastic proton pump 116 kda subunit) (oc-116 kda) (oc116) (t-cell immune regulator 1) (t cell immune response cdna7 protein) (tirc7). [source:swissprot;acc:q13488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5890.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6547.81\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
789\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal v0 subunit a isoform 4; vacuolar proton pump 116 kda accessory subunit; vacuolar proton pump, subunit 2; h(+)-transporting two-sector atpase, noncatalytic accessory protein 1b; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 1b; renal tubular acidosis; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 2 (38kd). [source:refseq;acc:nm\_020632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5890.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6547.99\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1116\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
790\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 1 (clathrin-coated vesicle/synaptic vesicle proton pump 116 kda subunit) (vacuolar proton pump subunit 1) (vacuolar adenosine triphosphatase subunit ac116). [source:swissprot;acc:q93050]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5890.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6548.28\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
791\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 3; wd-repeat protein sazd. [source:refseq;acc:nm\_006453]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4025.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4474.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11154\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
792\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
axonemal dynein light intermediate polypeptide 1 (inner dynein arm light chain, axonemal) (hp28). [source:swissprot;acc:o14645]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6772.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7526.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11125\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
793\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative n6-dna-methyltransferase (ec 2.1.1.-) (protein pred28) (m.hsahemk2p). [source:swissprot;acc:q9y5n5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5036.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5596.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11107\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna topoisomerase ii, alpha isozyme (ec 5.99.1.3). [source:swissprot;acc:p11388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6441.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7154.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11075\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
795\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna topoisomerase ii, beta isozyme (ec 5.99.1.3). [source:swissprot;acc:q02880]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6441.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7154.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11069\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
796\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear receptor co-repressor/hdac3 complex subunit tblr1 (tbl1- related protein 1). [source:swissprot;acc:q9bzk7]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6834.54\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7590.49\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11061\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
797\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin beta-1 subunit (karyopherin beta-1 subunit) (nuclear factor p97) (importin 90). [source:swissprot;acc:q14974]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
798\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 1x protein (transducin-beta-like 1, x-linked). [source:swissprot;acc:o60907]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
799\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 1y protein (transducin-beta-like 1, y-linked). [source:swissprot;acc:q9bq87]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
800\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nr6a1 (germ cell nuclear factor) (gcnf) (retinoid receptor-related testis specific receptor) (rtr). [source:swissprot;acc:q15406]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6075.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6746.92\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1105\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
801\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-3 subunit (karyopherin alpha-3 subunit) (srp1-gamma). [source:swissprot;acc:o00505]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6456.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7169.75\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
802\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
target of egr1, member 1 (nuclear); target of egr1, member 1. [source:refseq;acc:nm\_025077]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6455.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7168.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11047\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
803\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-4 subunit (karyopherin alpha-4 subunit) (qip1 protein). [source:swissprot;acc:o00629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6455.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7167.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11045\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
804\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase b22 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b22) (ci-b22). [source:swissprot;acc:q9y6m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6770.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7517.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11036\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
805\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l39. [source:swissprot;acc:p02404]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4708.61\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5226.71\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11003\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
806\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l18a. [source:swissprot;acc:q02543]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
807\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s19. [source:swissprot;acc:p39019]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/